Orchid Pharma Limited
₹546.6-2.17%Apr 13, 3:45 PM IST
ORCHPHARMA•Health Technology•Pharmaceuticals: Major
Current Price
₹546.6-2.17%
Apr 13, 3:45 PM ISTMarket Cap₹2,836.21 Cr
Market Cap₹2,836.21 Cr
Business Overview
Orchid Pharma Limited operates through 1 main business divisions including Cephalosporin Pharmaceuticals.
Business Hierarchy Structure for Orchid Pharma Limited
- Orchid Pharma Limited
- Cephalosporin Pharmaceuticals
- Active Pharmaceutical Ingredients (API)
- Oral
- Sterile
- Finished Dosage Formulations
- General Category Finished Dosage Formulations
- Anti-infective Finished Dosage Formulations
- Antibiotics
- Beta-lactam
- Cephalosporins
- Macrolide
- Fluoroquinolone
- Imidazole
- Beta-lactam
- Research & Development / Product Development
- Specific Products/Developments
- Enmetazobactam (Novel Combination Drug)
- Cefepime Hydrochloride (4th Generation Cephalosporin)
- Cefepime + Enmetazobactam (Combination Drug)
- Key Raw Materials
- 7ACA
- Specific Products/Developments
- Active Pharmaceutical Ingredients (API)
- Cephalosporin Pharmaceuticals